Cabaletta Bio, Inc.
CABA
$1.21
$0.054.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -32.59M | -30.63M | -27.60M | -25.05M | -20.89M |
| Total Depreciation and Amortization | 468.00K | 424.00K | 426.00K | 393.00K | 336.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.12M | 6.98M | 6.42M | 4.80M | 3.45M |
| Change in Net Operating Assets | 2.87M | 2.90M | -31.00K | -4.13M | 654.00K |
| Cash from Operations | -23.12M | -20.32M | -20.79M | -23.99M | -16.45M |
| Capital Expenditure | -376.00K | -253.00K | -770.00K | -812.00K | -185.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.50M | 12.50M | 24.50M | -- | 1.32M |
| Cash from Investing | 12.12M | 12.25M | 23.73M | -812.00K | 1.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -897.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 5.27M | 71.00K | 379.00K | 6.86M | 93.05M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.37M | 71.00K | 379.00K | 6.86M | 93.05M |
| Foreign Exchange rate Adjustments | -20.00K | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.65M | -8.01M | 3.32M | -17.95M | 77.74M |